By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Drug Development20.6M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
Outside of the United States19.16M92.99%
United States1.44M7.01%